Dysaesthesia in diabetic polyneuropathy.
In case of severe dysaesthesia in diabetic polyneuropathy, the intravenous administration of 600 mg alpha-lipoic acid daily (equals one injection bottle Thiogamma® Turbo-Set) is recommended in adults.
In the initial treatment phase, the injection is administered intravenously over a period of two to four weeks. The intravenous administration should be carried out slowly, administering the content as a short infusion for at least 30 minutes. The infusion is administered directly out of the bottle, using a standard infusion set and the attached light protection bag. Since the active substance is light sensitive, the injection bottle should be removed from the folding box shortly before use. The minimum infusion duration of 30 minutes has to be ensured.
For maintenance therapy 300-600 mg alpha-lipoic acid in oral dosage form is applied.
One injection bottle containing 50 ml of injection solution contains 1.167,70 mg alpha-lipoic acid meglumine salt (equivalent to 600 mg alpha-lipoic acid). For other ingredients, please refer to the directions of use.
Thiogamma® Turbo-Set. Active substance: alpha-lipoic acid. Therapeutic indications: Dysaesthesia in diabetic polyneuropathy. If you have any questions about risks and side effects, please read the patient information leaflet and ask your doctor or pharmacist. Wörwag Pharma GmbH & Co. KG, 71034 Böblingen
5 x 50 ml infusion solution and 5 light protection pouches, 5 IV needles und 5 IV administration sets: PZN 00921438
10 x 50 ml infusion solution and 10 light protection pouches, 10 IV needles und 10 IV administration sets: PZN 00921444
1 x 50 ml infusion solution and one light protection pouch: PZN 03645849 (pure)
10 x 50 ml infusion solution and 10 light protection pouches: PZN 00921450 (pure)